Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib plus irinotecan in TNBC brain metastasis
NCT01173497Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iniparib in triple-negative breast cancer (TNBC), sponsored by Sanofi. Started Jul 2010; status: completed.
02
Drugs
iniparib
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01173497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173497.